Sanjeev Khatri

Managing Director

The testing, inspection, and auditing services domain is growing rapidly as a result of the rising demand for accurate, standardized, and regulation-compliant tests across industries including pharmaceuticals, food, agricultur­al commodities, biotechnology, feed, nutraceuticals, and en­vironment.

As the industry grows, Eureka Analytical Services, a prominent service provider within this domain with labs in Bangalore, Delhi-NCR, Navi Mumbai, Andhra Pradesh, and Gujarat, emerges as a reliable partner. Eureka is a part of GBA Group, headquartered in Germany. GBA is a leading bioanalytical testing company in Europe, offering a suite of reliable and comprehensive analytical services. Established by seasoned professionals with vast and diverse experience backing them up, Eureka provides a comprehensive portfolio of analytical methods in its various TIC (testing-inspection-certification) services.

High Standards of Quality

Eureka offers an array of testing and validation services encompassing Pharmaceutical testing, cosmetics and personal care products testing, and other services. Within this portfolio, the company also offers specific cGMP pharmaceutical testing solutions that are aligned with international regulatory standards such as raw material testing, finished product testing, cleaning validation, microbiological testing, stability studies, impurity profiling and characterization, and regulatory compliance and support.

To ensure the quality of its services, particularly for pharmacopoeial testing procedures, the firm leverages an experienced and knowledgeable team of experts who also receive ongoing training, guaranteeing that the teams are abreast of the latest advancements and regulatory changes in the industry. Eureka invests in modern lab facilities with 21 CFR compliance and cutting-edge equipment like HPLC, GC, LCMSMS, GCHS, ICPMS, DSC, Malvern analyzers, and spectrophotometers, among others, and technology that ensures that such testing provides accurate results. Eureka also ensures that the testing processes comply with the pharmacopoeial monograph criteria, and strict quality assurance protocols are followed at every testing stage aligned with GMP and GLP practices. It maintains comprehensive records to facilitate audits and guarantee accountability, in addition to participating in relevant programs.

“Our knowledge and expertise in creating and evaluating pharmaceutical procedures for a wide range of applications show our dedication to offering creative, superior analytical solutions that satisfy the particular requirements of our customers and advance pharmaceutical science and healthcare. Moreover, leveraging an extensive network of laboratories, we gain benefits like providing local support, quick turnaround times, and superior analytical testing services, ultimately contributing to client satisfaction”, shares Dr. Gouri Satpathy, Executive Director.

Eureka’s network of laboratories offers the company a competitive advantage by allowing users easier and more convenient access, minimizing delays and costs. Furthermore, the company benefits from the local knowledge of pertinent industry norms in the area, along with customer preferences and restrictions, ensuring customized services are extended to clients in diverse regions. Quick turnaround times for sample analysis is yet another advantage along with the flexibility and scalability that it offers in handling various samples, and the diversity of services that the various labs can provide.

Future Roadmap

“Our commitment to our customers is to provide the best in class analytical, testing, and related services to ensure safety and compliance with standards and specifications, follow the latest methods and practices, and ensure that results are accurate, reliable, and reproducible. It is our aim to constantly benchwork our services with global standards and competition to improve on what we do and to actively seek customer feedback to ensure we meet and exceed expectations. Our future roadmap aligns with these values”, shares Sanjeev Khatri, Managing Director.

Aligned with the core values that are fueling the company’s ethos and everyday operations, Eureka has a multifaceted plan for its future expansion which focuses on an all-round development of the company. The primary goal for Eureka is to expand its service offerings to meet the dynamic and growing market needs and capitalize on the opportunities that it presents.

Beyond this, the company is also preparing to invest considerably in technology, digital transformation, and infrastructure to ensure the precision and effectiveness of its solutions. Geographical expansion that focuses on establishing a global presence and market reach is another key focus area for Eureka, to acquire new clients and grow its prominence further. Eureka’s extra focus on innovation and R&D will also be refined to fuel these goals of expansion and to ensure that the firm remains at the forefront of technological advancements. The firm will also invest time and energy into prioritizing regulatory compliance and quality assurance to retain its leading position and trust among clients in addition to integrating sustainability and social responsibility initiatives into its operations in line with the global sustainability goals.

Through this combination of strategic growth initiatives which incline equally on innovation, expansion, sustainability, and continuous improvement, Eureka aims to grow significantly in the coming years and take a leading position in the industry. Eureka is also into food testing, vegan testing, herbal testing, and environment testing.